LEADER 00917nam0-2200325---450 001 990008809130403321 005 20190702093446.0 010 $a978-1-84569-060-1 035 $a000880913 035 $aFED01000880913 035 $a(Aleph)000880913FED01 035 $a000880913 100 $a20090219d2007----km-y0itay50------ba 101 0 $aeng 102 $aUS 105 $aa-------001yy 200 1 $aCheese problems solved$fedited by P.L.H. McSweeney 210 $aCambridge (Mass.)$cWoodhead$aBoca Raton$cCRC Press$dc2007 215 $aXXI, 402 p.$cill.$d24 cm 610 0 $aFormaggio 676 $a637.3$v20$zita 702 1$aMcSweeney,$bP. L. H. 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990008809130403321 952 $a60 637.3 MCSP 2007$b11635$fFAGBC 952 $a60 637.3 B 8$b11999$fFAGBC 959 $aFAGBC 996 $aCheese problems solved$9807980 997 $aUNINA LEADER 08937nam 2202677z- 450 001 9910557631703321 005 20210501 035 $a(CKB)5400000000045097 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/68656 035 $a(oapen)doab68656 035 $a(EXLCZ)995400000000045097 100 $a20202105d2020 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aPeptides for Health Benefits 2019$eVolume 1 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2020 215 $a1 online resource (340 p.) 311 08$a3-03936-080-9 311 08$a3-03936-081-7 330 $aIn recent years, peptides have received increased interest from the pharmaceutical industry. The high potency, specificity, and safety profile are the main strengths of bioactive peptides as new and promising therapies that may fill the gap between small molecules and protein drugs. These positive attributes have renewed interest in the discovery, optimization, and development of peptides as pharmacological therapy. Among bioactive peptides, those released from food sources have acquired importance as nutraceutical and active components in functional foods because they possess regulatory functions that can lead to health benefits. This Special Issue covers a selection of recent research papers and reviews in the field of bioactive peptides. It covers all aspects of peptide research in relation to health promotion. In particular, it emphasizes current knowledge and research trends concerning bioactive peptides, including identification and quantification of peptides from new sources, methods for their production and purification, structure-function relationships, mechanisms of action, in vitro and in vivo assays for the evaluation of their bioactivity, physiological evidence to support health benefits, and peptide stability and bioavailability. Papers regarding the development of new drugs, functional foods, or nutraceuticals based on bioactive peptides were also considered. 517 $aPeptides for Health Benefits 2019 606 $aBiology, life sciences$2bicssc 606 $aResearch & information: general$2bicssc 610 $aACE-inhibitory activity 610 $aacrylamide 610 $aairway inflammation 610 $aalcalase hydrolysate 610 $aAlzheimer's disease 610 $aAMD 610 $aAMP identification and design 610 $aamyloid 610 $aamyloid fibrils 610 $aand endothelial regeneration 610 $aangiogenic precursor cells 610 $aangiotensin I converting enzyme 610 $aanti-biofilm peptides 610 $aanti-inflammatory 610 $aantibiotic resistance 610 $aantifungal activity 610 $aantigen-specific 610 $aantihypertensive peptides 610 $aantimicrobial peptide 610 $aantimicrobial peptides 610 $aantimicrobial peptides (AMPs) 610 $aantimicrobial resistance 610 $aantioxidant activity 610 $aantioxidant peptide 610 $aantiproliferative assay 610 $aantisepsis, peptide antibiotics 610 $aapolipoprotein E 610 $aarthritis 610 $aasthma 610 $aA? peptide 610 $abioactive peptide 610 $abioactive peptides 610 $abiomarkers 610 $aBIOPEP-UWM database 610 $abiosynthesis 610 $abone erosion 610 $acancer antigen 610 $acancer stem cells 610 $acartilage destruction 610 $acathelicidins 610 $aCec-analogs 610 $aCecropins 610 $acentral nervous system diseases 610 $achemoprevention 610 $aChlorella sorokiniana 610 $achronic diseases 610 $aClostridioides difficile 610 $aCNV 610 $acollagen 610 $acollagen peptide 610 $acolorectal cancer 610 $acombinatorial library 610 $aconfocal microscopy 610 $aconjugation 610 $acopper 610 $aCrassostrea angulata 610 $acryptides 610 $aCXCR3 610 $acystic fibrosis 610 $acytoprotective effect 610 $adatabase 610 $adefensins 610 $adiseases 610 $adocetaxel 610 $adoxorubicin 610 $adry-cured pork ham 610 $adyslipidemia 610 $aendothelial dysfunction 610 $aendothelial progenitor cells 610 $aenergy expenditure 610 $aenteric nervous system 610 $aenzyme 610 $aextra domain B 610 $afermentation 610 $afetal bovine serum (FBS) 610 $afibroblasts 610 $afibronectin 610 $aFmoc/tBu 610 $afood intake regulation 610 $afood-derived 610 $afoods 610 $aformyl peptide receptors 610 $aFPYLRH 610 $afresh tissue 610 $afunctional food 610 $agalanin 610 $agender differences 610 $aglioma 610 $aGPR10 610 $aHistatin-5 610 $ahost defense peptides 610 $aHs02 610 $ahuman antimicrobial peptides 610 $ahuman keratinocytes 610 $ahumanized mouse 610 $ahybrid peptide 610 $ahydrolysis 610 $ahydroxyprolyl-glycine (Hyp-Gly) 610 $ahyperglycemia 610 $ahypertension 610 $aimmune checkpoint inhibitor 610 $aimmune response 610 $aimmune suppression 610 $aimmunomodulant 610 $ain silico 610 $aIn situ tetramer staining 610 $ainflammation 610 $ainflammatory bowel disease 610 $ainsects 610 $aintragenic antimicrobial peptide 610 $aLactoferricin B (Lfcin B) 610 $alibrary design 610 $aligands 610 $alunasin 610 $aMDA 610 $aMDR infectious diseases 610 $amembrane activity 610 $aMHC tetramer 610 $amigration 610 $amiiuy croaker (Miichthys miiuy) 610 $amode of action 610 $amolecular blind docking 610 $amolecular docking 610 $amolecular weight 610 $amonocyte 610 $aMRSA 610 $amultimeric peptides 610 $amutagenesis 610 $an/a 610 $anano liquid chromatography tandem mass spectrometry (nanoLC-nanoESI MS/MS) 610 $aneuroprotection 610 $aneurotensin 610 $aNF-?B 610 $anon-atopic asthma 610 $anutraceuticals 610 $anutrition 610 $aobesity 610 $aoral delivery 610 $aosteostatin 610 $aoxidative stress 610 $apegylated glucagon-like peptide 1 610 $apeptide 610 $apeptide vaccine 610 $apeptide-drug conjugate 610 $aphysico-chemical properties 610 $aPI3K/Akt pathway 610 $apidotimod 610 $apig 610 $apiscidins 610 $aplatelets 610 $apolymicrobial biofilms 610 $apro-inflammatory 610 $apro-inflammatory cytokines 610 $aprolactin-releasing peptide 610 $aprolyl-hydroxyproline (Pro-Hyp) 610 $aprostate cancer 610 $aprotection ability 610 $aproteolysis 610 $aproteome microarray 610 $aproteomics 610 $apseudin-2 610 $aPseudomonas aeruginosa 610 $apulmonary emphysema 610 $aRF-amide peptides 610 $arheumatic diseases 610 $ascreening 610 $asheepskin 610 $asignaling 610 $aSjo?gren's syndrome 610 $aSMILES code 610 $asolid-phase synthesis 610 $asPLA2 610 $aStaphylococcus aureus 610 $astomach 610 $aswim bladder 610 $asynergistic effects 610 $asynergy 610 $aT cell 610 $aT cells 610 $atargeting 610 $atemporin 610 $atherapeutic potential 610 $atype 1 diabetes 610 $avasoactive intestinal peptide 610 $aVEGFR1 610 $avelvet antler 610 $aVPAC1 receptor 610 $aVPAC2 receptor 610 $awhey peptides 610 $a?? oligomer 615 7$aBiology, life sciences 615 7$aResearch & information: general 700 $aHerna?ndez-Ledesma$b Blanca$4edt$0906315 702 $aMarti?nez-Villaluenga$b Cristina$4edt 702 $aHerna?ndez-Ledesma$b Blanca$4oth 702 $aMarti?nez-Villaluenga$b Cristina$4oth 906 $aBOOK 912 $a9910557631703321 996 $aPeptides for Health Benefits 2019$93013216 997 $aUNINA